Nisa Investment Advisors
PYXS icon

Nisa Investment Advisors’s Pyxis Oncology PYXS Stock Holding History

Nisa Investment Advisors’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.89K Hold
961
– – ﹤0.01% 2701
2026
Q1 		$1.4K Hold
961
– – ﹤0.01% 2680
2025
Q4 		$1.1K Hold
961
– – ﹤0.01% 2701
2025
Q3 		$2.13K Hold
961
– – ﹤0.01% 2605
2025
Q2 		$1.06K Buy
961
+661
+220% +$745 ﹤0.01% 2726
2025
Q1 		$294 Buy
+300
New +$400 ﹤0.01% 2875
2024
Q4 		– Sell
-118
Closed -$433 – 3045
2024
Q3 		$433 Buy
+118
New +$413 ﹤0.01% 2745

Other funds holding PYXS

GGI
GordonMD Global Investments Beverely Hills, California $207M AUM
P
Pfizer New York $170M AUM 191.09% 1-Year Est. Return
LCM
Laurion Capital Management New York $3.9B AUM 75.03% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
HP
HealthInvest Partners Stockholm, Sweden $372M AUM 59.89% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nisa Investment Advisors's PYXS Position: Q2 2026 in Review

Nisa Investment Advisors held its Pyxis Oncology (PYXS) position steady in Q2 2026 at 961 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2701.

Nisa Investment Advisors first reported a position in PYXS in Q3 2024 and has held it in 7 quarters since. 76 funds tracked by Wall St. Rank hold PYXS as of Q2 2026.

  • Nisa Investment Advisors held 961 shares of Pyxis Oncology worth $2.89K as of Q2 2026.
  • Nisa Investment Advisors left its Pyxis Oncology share count unchanged in Q2 2026.
  • Pyxis Oncology made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2701 holding.
  • Nisa Investment Advisors first reported a position in Pyxis Oncology in Q3 2024 and has held it in 7 quarters since.
  • 76 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.